A detailed history of Sanctuary Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 14,812 shares of INCY stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,812
Previous 21,250 30.3%
Holding current value
$1.54 Million
Previous $1.45 Billion 38.02%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

SELL
$67.27 - $86.96 $433,084 - $559,848
-6,438 Reduced 30.3%
14,812 $897 Million
Q2 2025

Jan 06, 2026

BUY
$55.17 - $71.22 $355,184 - $458,514
6,438 Added 43.46%
21,250 $1.45 Billion
Q1 2025

Jan 06, 2026

SELL
$60.0 - $75.26 $751,080 - $942,104
-12,518 Reduced 45.8%
14,812 $897 Million
Q4 2024

Jan 31, 2025

BUY
$65.08 - $83.38 $408,311 - $523,126
6,274 Added 29.8%
27,330 $2.02 Billion
Q3 2024

Nov 25, 2024

BUY
$57.33 - $68.61 $1.21 Million - $1.44 Million
21,056 New
21,056 $1.51 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.